---
layout: post
title: "International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Pharmaceutical Development; Draft Guidance for Industry; Availability"
date: 2026-02-05 19:09:30 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-09777
original_published: 2024-05-06 00:00:00 +0000
significance: 8.00
---

# International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Pharmaceutical Development; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** May 06, 2024 00:00 UTC
**Document Number:** 2024-09777

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry (GFI) #290 (VICH GL61) entitled "Pharmaceutical Development." This draft guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). This draft guidance describes the suggested contents for the Pharmaceutical Development section, which provides an opportunity to present the knowledge gained through the application of scientific approaches and quality risk management to the development of a product and its manufacturing process.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/05/06/2024-09777/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary)
- API: https://www.federalregister.gov/api/v1/documents/2024-09777

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
